New Anticoagulants for Stroke Prophylaxis in Atrial Fibrillation
How do Compliance, Convenience, and Tolerability Affect Blood Pressure Goal Rates?
Tangier Disease
Anticoagulation Therapy for Patients with Non-Valvular Atrial Fibrillation
Efficacy of Olmesartan Medoxomil and Hydrochlorothiazide Fixed-Dose Combination Therapy in Patients Aged 65 Years and Older with Stage 1 and 2 Hypertension or Isolated Systolic Hypertension
Antihypertensive Effects of Olmesartan Compared with Other Angiotensin Receptor Blockers
High Prevalence of Silent Brain Infarction in Patients Presenting with Mechanical Heart Valve Thrombosis
Association of Cholesteryl Ester Transfer Protein Mass with Peripheral Leukocyte Count Following Statin Therapy